Evidence map›Paper›PMID 40144721›Full record

ArticleJHLT open2025

Sotatercept Use in a Patient with Pulmonary Arterial Hypertension Undergoing Lung Transplantation.

Justin P Rosenheck, Kashika Goyal, Tara Fallah, Pamela Burcham, Kukbin Choi, Matthew Henn, Elie Homsy, Scott Visovatti, Veronica Franco

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JHLT open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Justin P RosenheckOhio State University, Department of Internal Medicine, Division of Pulmonary Critical Care and Sleep Medicine, Davis Heart and Lung Institute, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH.
Kashika GoyalOhio State University, Department of Internal Medicine, Division of Pulmonary Critical Care and Sleep Medicine, Davis Heart and Lung Institute, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH.
Tara FallahOhio State University, College of Pharmacy, 217 Lloyd M. Parks Hall, 500 West 12th Ave, Columbus OH 43210.
Pamela BurchamOhio State University, College of Pharmacy, 217 Lloyd M. Parks Hall, 500 West 12th Ave, Columbus OH 43210.
Kukbin ChoiOhio State University, Department of Surgery, Division of Cardiac Surgery, 410 W. 10th Ave, Columbus OH 43210.
Matthew HennOhio State University, Department of Surgery, Division of Cardiac Surgery, 410 W. 10th Ave, Columbus OH 43210.
Elie HomsyOhio State University, Department of Internal Medicine, Division of Pulmonary Critical Care and Sleep Medicine, Davis Heart and Lung Institute, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH.
Scott VisovattiOhio State University, Department of Internal Medicine, Division of Cardiovascular Medicine, 452 W 10th Ave, Columbus, OH 43210.
Veronica FrancoOhio State University, Department of Internal Medicine, Division of Cardiovascular Medicine, 452 W 10th Ave, Columbus, OH 43210.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary arterial hypertension (PAH) is one of the common indications for lung transplantation. Sotatercept is a new medication with a novel mechanism of action and was recently approved for the treatment of PAH. Sotatercept is associated with significant adverse effects including thrombocytopenia and erythrocytosis which can impact outcomes of lung transplantation. This is the first described case of a patient undergoing lung transplantation while receiving sotatercept for PAH.

Indexed as

Group 1Lung TransplantPAHPulmonary Arterial HypertensionSotatercept

Identifiers

PMID40144721
PMCPMC11935506

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.